Friday, 12 September 2014

Ebola



Ebola virus disease
Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys and chimpanzees) that has appeared sporadically since its initial recognition in 1976.
Ebola first appeared in 1976 in 2 simultaneous outbreaks, in Nzara, Sudan, and in Yambuku, Democratic Republic of Congo. The latter was in a village situated near the Ebola River, from which the disease takes its name.
Genus Ebolavirus is 1 of 3 members of the Filoviridae family (filovirus), along with genus Marburgvirus and genus Cuevavirus. 

Marburgvirus and genus Cuevavirus. Genus Ebolavirus comprises 5 distinct species:

  • 1.      Bundibugyo ebolavirus (BDBV)
  • 2.      Zaire ebolavirus (EBOV)
  • 3.      Reston ebolavirus (RESTV)
  • 4.      Sudan ebolavirus (SUDV)
  • 5.      Taï Forest ebolavirus (TAFV).

BDBV, EBOV, and SUDV have been associated with large EVD outbreaks in Africa, whereas RESTV and TAFV have not. The RESTV species, found in Philippines and the People’s Republic of China, can infect humans, but no illness or death in humans from this species has been reported to date.



Transmission

Ebola is introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals. In Africa, infection has been documented through the handling of infected chimpanzees, gorillas, fruit bats, monkeys, forest antelope and porcupines found ill or dead or in the rainforest.

Ebola then spreads in the community through human-to-human transmission, with infection resulting from direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and indirect contact with environments contaminated with such fluids. Burial ceremonies in which mourners have direct contact with the body of the deceased person can also play a role in the transmission of Ebola. Men who have recovered from the disease can still transmit the virus through their semen for up to 7 weeks after recovery from illness.

Health-care workers have frequently been infected while treating patients with suspected or confirmed EVD. This has occurred through close contact with patients when infection control precautions are not strictly practiced.

Among workers in contact with monkeys or pigs infected with Reston ebolavirus, several infections have been documented in people who were clinically asymptomatic. Thus, RESTV appears less capable of causing disease in humans than other Ebola species.

However, the only available evidence available comes from healthy adult males. It would be premature to extrapolate the health effects of the virus to all population groups, such as immuno-compromised persons, persons with underlying medical conditions, pregnant women and children. More studies of RESTV are needed before definitive conclusions can be drawn about the pathogenicity and virulence of this virus in humans.











































Signs and symptoms

EVD is a severe acute viral illness often characterized by the sudden onset of fever, intense weakness, muscle pain, headache and sore throat. This is followed by vomiting, diarrhoea, rash, impaired kidney and liver function, and in some cases, both internal and external bleeding. Laboratory findings include low white blood cell and platelet counts and elevated liver enzymes.
People are infectious as long as their blood and secretions contain the virus. Ebola virus was isolated from semen 61 days after onset of illness in a man who was infected in a laboratory.
The incubation period, that is, the time interval from infection with the virus to onset of symptoms, is 2 to 21 days.



Diagnosis

Other diseases that should be ruled out before a diagnosis of EVD can be made include: malaria, typhoid fever, shigellosis, cholera, leptospirosis, plague, rickettsiosis, relapsing fever, meningitis, hepatitis and other viral haemorrhagic fevers.
Ebola virus infections can be diagnosed definitively in a laboratory through several types of tests:
  •          antibody-capture enzyme-linked immunosorbent assay (ELISA)
  •          antigen detection tests
  •          serum neutralization test
  •          reverse transcriptase polymerase chain reaction (RT-PCR) assay
  •          electron microscopy
  •       virus isolation by cell culture.

Samples from patients are an extreme biohazard risk; testing should be conducted under maximum biological containment conditions.



Vaccine and treatment

No licensed vaccine for EVD is available. Several vaccines are being tested, but none are available for clinical use.
Severely ill patients require intensive supportive care. Patients are frequently dehydrated and require oral rehydration with solutions containing electrolytes or intravenous fluids.
No specific treatment is available. New drug therapies are being evaluated.


Favipiravir looks like it may be useful in a mouse model of the disease. Estrogen receptor drugs used to treat infertility and breast cancer (clomiphene and toremifene) inhibit the progress of Ebola virus in infected mice. Ninety percent of the mice treated with clomiphene and fifty percent of those treated with toremifene survived the tests. Given their oral availability and history of human use, these drugs would be candidates for treating Ebola virus infection in remote geographical locations, either on their own or together with other antiviral drugs.




Prevention and control

Controlling Reston ebolavirus in domestic animals
No animal vaccine against RESTV is available. Routine cleaning and disinfection of pig or monkey farms (with sodium hypochlorite or other detergents) should be effective in inactivating the virus.
If an outbreak is suspected, the premises should be quarantined immediately. Culling of infected animals, with close supervision of burial or incineration of carcasses, may be necessary to reduce the risk of animal-to-human transmission. Restricting or banning the movement of animals from infected farms to other areas can reduce the spread of the disease.
As RESTV outbreaks in pigs and monkeys have preceded human infections, the establishment of an active animal health surveillance system to detect new cases is essential in providing early warning for veterinary and human public health authorities.


Reducing the risk of Ebola infection in people
In the absence of effective treatment and a human vaccine, raising awareness of the risk factors for Ebola infection and the protective measures individuals can take is the only way to reduce human infection and death.

In Africa, during EVD outbreaks, educational public health messages for risk reduction should focus on several factors:
·         Reducing the risk of wildlife-to-human transmission from contact with infected fruit bats or monkeys/apes and the consumption of their raw meat. Animals should be handled with gloves and other appropriate protective clothing. Animal products (blood and meat) should be thoroughly cooked before consumption.

·         Reducing the risk of human-to-human transmission in the community arising from direct or close contact with infected patients, particularly with their bodily fluids. Close physical contact with Ebola patients should be avoided. Gloves and appropriate personal protective equipment should be worn when taking care of ill patients at home. Regular hand washing is required after visiting patients in hospital, as well as after taking care of patients at home.
·         Communities affected by Ebola should inform the population about the nature of the disease and about outbreak containment measures, including burial of the dead. People who have died from Ebola should be promptly and safely buried.

Pig farms in Africa can play a role in the amplification of infection because of the presence of fruit bats on these farms. Appropriate biosecurity measures should be in place to limit transmission. For RESTV, educational public health messages should focus on reducing the risk of pig-to-human transmission as a result of unsafe animal husbandry and slaughtering practices, and unsafe consumption of fresh blood, raw milk or animal tissue. Gloves and other appropriate protective clothing should be worn when handling sick animals or their tissues and when slaughtering animals. In regions where RESTV has been reported in pigs, all animal products (blood, meat and milk) should be thoroughly cooked before eating.



Controlling infection in health-care settings
Human-to-human transmission of the Ebola virus is primarily associated with direct or indirect contact with blood and body fluids. Transmission to health-care workers has been reported when appropriate infection control measures have not been observed.
It is not always possible to identify patients with EBV early because initial symptoms may be non-specific. For this reason, it is important that health-care workers apply standard precautions consistently with all patients – regardless of their diagnosis – in all work practices at all times. These include basic hand hygiene, respiratory hygiene, the use of personal protective equipment (according to the risk of splashes or other contact with infected materials), safe injection practices and safe burial practices.
Health-care workers caring for patients with suspected or confirmed Ebola virus should apply, in addition to standard precautions, other infection control measures to avoid any exposure to the patient’s blood and body fluids and direct unprotected contact with the possibly contaminated environment. When in close contact (within 1 metre) of patients with EBV, health-care workers should wear face protection (a face shield or a medical mask and goggles), a clean, non-sterile long-sleeved gown, and gloves (sterile gloves for some procedures).
Laboratory workers are also at risk. Samples taken from suspected human and animal Ebola cases for diagnosis should be handled by trained staff and processed in suitably equipped laboratories.







Monday, 4 November 2013

Bengal gram - Reduces diabetes risk!!

The chickpea (Cicer arietinum) is a legumeof the family Fabaceae, subfamily Fabiodeae . Its seeds are high in Protein. It is one of the earliest cultivated legumes: 7,500-year-old remains have been found in the Middle East.
Other common names for the species include garbanzo bean, ceci bean, sanagalu, chana and Bengal gram.

Bengal gram reduces diabetes risk, finds study:


Consumption of Bengal gram prior to a meal could lower your risk of diabetes, according to a new study.
A team of scientists from the Indian Institute of Chemical Technology (IICT) compared the effectiveness of three commonly consumed legumes - Bengal gram, green gram and another variant of chickpea, Kabuli Channa in regulating carbohydrate digestion.
The study found that Bengal gram showed consistent results in terms of reducing sugar spikes after a starchy meal. Eating about 50 grams of sprouted raw Bengal gram before a meal will rein in blood glucose levels which usually witness a jump due to the rapid absorption of carbohydrates after a meal, the study headed by scientist A K Tiwari, concluded.
Tiwari said the study was aimed at finding the varieties of sprouts which are most beneficial for improving the health of diabetics. "The benefits of sprouts are well-known. But our study specifically shows how diabetics can prevent sugar spikes to delay the onset or in some cases, even prevent the disease," he said.
Tiwari highlighted the importance of high amount of protein and presence of digestion-resistant carbohydrate in Bengal gram.
" A protein-rich diet takes longer to be absorbed by our system. The presence of digestion-resistant carbohydrates further reduces the rate of absorption of carbohydrates into our bloodstream," he said adding that the Bengal Gram should ideally be consumed raw after germination. 
Tiwari conducted similar studies in the past.
The findings of the latest study were published in the Journal of Pharmacy and Bio-Allied Sciences.
Source: Indian Institute of Chemical Technology (IICT)








Thursday, 25 July 2013

Cow urine cure gets scientific stamp!


FROM  "TIMES OF INDIA"
Study Proves Cow Urine Removes Kidney Stones 

Vijaysinh Parmar | TNN 

Rajkot: Most would cringe at the thought of drinking cow urine,even if given in a distilled form that is tasteless and odourless.However,ancient scriptures that often proclaim its disease-fighting properties have finally got scientific backing.


A recent study by Bhavnagar Medical College has proved that distilled cow urine is indeed effective in curing kidney stones.The research conducted by the colleges pharmacology department is touted to be first-ever scientific evidence suggesting beneficial properties of cow urine in treating renal disorders.


It must be noted that major part of Saurashtra,mostly coastal areas,is considered to be a renal stone belt with nearly 30% suffering from kidney stones.


Cow urine was given to albino rats after inducing renal stones in them using ethylene glycol.The results are very encouraging as we found significant reduction in urinary oxalate level and calcium oxalate crystals formation in kidney, said Dr Apexa Shukla,a student of MD (pharmacology),who led the team conducting the study.


Distilled cow urine is tasteless and free from contamination,she added.
The research paper titled Anti-Urolithiatic Effect of Cow Urine Ark on Ethylene Glycol-Induced Renal Calculi has also been accepted for publication in the International Brazil Journal of Urology,the official journal of Brazilian Society of Urology.


Cow urine is known to have diuretic and nephroprotective effect.However,there was never a scientific backing for this agesold claim, said Dr C B Tripathi,associate professor,pharmacology department.


The college is now in talks with Government Ayurvedic College to carry out trials on humans.

Wednesday, 24 July 2013

Remembering Rosalind Franklin

Rosalind Franklin

( July 25, 1920-April 16, 1958)


There is probably no other woman scientist with as much controversy surrounding her life and work as Rosalind Franklin. Franklin was responsible for much of the research and discovery work that led to the understanding of the structure of deoxyribonucleic acid, DNA. The story of DNA is a tale of competition and intrigue, told one way in James Watson's book The Double Helix, and quite another in Anne Sayre's study, Rosalind Franklin and DNA. James Watson, Francis Crick, and Maurice Wilkins received a Nobel Prize for the double-helix model of DNA in 1962, four years after Franklin's death at age 37 from ovarian cancer.
Franklin excelled at science and attended one of the few girls' schools in London that taught physics and chemistry. When she was 15, she decided to become a scientist. Her father was decidedly against higher education for women and wanted Rosalind to be a social worker. Ultimately he relented, and in 1938 she enrolled at Newnham College, Cambridge, graduating in 1941. She held a graduate fellowship for a year, but quit in 1942 to work at the British Coal Utilization Research Association, where she made fundamental studies of carbon and graphite microstructures. This work was the basis of her doctorate in physical chemistry, which she earned from Cambridge University in 1945.
After Cambridge, she spent three productive years (1947-1950) in Paris at the Laboratoire Central des Services Chimiques de L'Etat, where she learned X-ray diffraction techniques. In 1951, she returned to England as a research associate in John Randall's laboratory at King's College, London.
It was in Randall's lab that she crossed paths with Maurice Wilkins. She and Wilkins led separate research groups and had separate projects, although both were concerned with DNA. When Randall gave Franklin responsibility for her DNA project, no one had worked on it for months. Wilkins was away at the time, and when he returned he misunderstood her role, behaving as though she were a technical assistant. Both scientists were actually peers. His mistake, acknowledged but never overcome, was not surprising given the climate for women at the university then. Only males were allowed in the university dining rooms, and after hours Franklin's colleagues went to men-only pubs.
But Franklin persisted on the DNA project. J. D. Bernal called her X-ray photographs of DNA, "the most beautiful X-ray photographs of any substance ever taken." Between 1951 and 1953 Rosalind Franklin came very close to solving the DNA structure. She was beaten to publication by Crick and Watson in part because of the friction between Wilkins and herself. At one point, Wilkins showed Watson one of Franklin's crystallographic portraits of DNA. When he saw the picture, the solution became apparent to him, and the results went into an article in Nature almost immediately. Franklin's work did appear as a supporting article in the same issue of the journal.
A debate about the amount of credit due to Franklin continues. What is clear is that she did have a meaningful role in learning the structure of DNA and that she was a scientist of the first rank. Franklin moved to J. D. Bernal's lab at Birkbeck College, where she did very fruitful work on the tobacco mosaic virus. She also began work on the polio virus. In the summer of 1956, Rosalind Franklin became ill with cancer. She died less than two years later.

Thanks to Rosalind Franklin on her 93rd Birthday